SCHEMBL11010247

SCHEMBL11010247

N#CC1CN1OCc1cccc(C(N)=O)c1

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ OPRK1 P41145 9/20 0.41
▸ KCNH2 Q12809 7/20 0.40
▸ OPRM1 P35372 6/20 0.40
▸ OPRD1 P41143 5/20 0.40
▸ MRGPRX4 Q96LA9 2/20 0.39
▸ PARP1 P09874 2/20 0.39
▸ KDM1A O60341 2/20 0.39
▸ MAOB P27338 2/20 0.39
▸ MAOA P21397 1/20 0.39
▸ FOLH1 Q04609 1/20 0.38
▸ PARP10 Q53GL7 2/20 0.37
▸ MEP1B Q16820 1/20 0.37
▸ PARP15 Q460N3 1/20 0.37
▸ PARP14 Q460N5 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11152762 0.78 OPRK1 (0.44) OPRK1KCNH2OPRM1OPRD1KDM1A
SCHEMBL11003582 0.78 IDO1 (0.45) MAOB
SCHEMBL11006655 0.76 CTSL (0.49) MAOB
SCHEMBL11010407 0.71 SIGMAR1 (0.44) —
SCHEMBL11166191 0.69 IDO1 (0.46) MAOBMAOA
SCHEMBL11160529 0.69 DPP4 (0.41) —
SCHEMBL2857119 0.69 ENPP2 (0.50) PARP1KDM1AMAOBMAOAFOLH1
SCHEMBL2824632 0.69 PARP1 (0.56) MRGPRX4PARP1MAOBPARP10MEP1B
SCHEMBL6802864 0.69 PARP1 (0.42) MRGPRX4PARP1MAOBFOLH1PARP10
SCHEMBL11004916 0.68 PREP (0.48) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4517183-A COMBATING DISEASES WITH WEAKNESS OF IMMUNE SYSTEMS BOEHRINGER MANNHEIM GMBH (DE) 1985-05-14 — — US disclosed
US-4397848-A ANTITUMOR ACTIVITY BOEHRINGER MANNHEIM GMBH (DE) 1983-08-09 — — US disclosed
EP-0014976-A1 N-substituted 2-cyanaziridines, methods for their preparation and medicaments containing them, correspondingly substituted aziridine-2-carbonamides and their preparation Roche Diagnostics GmbH (DE) 1980-09-03 — — EP disclosed
Send feedback